Ubs Asset Management Americas Inc Homology Medicines, Inc. Transaction History

Ubs Asset Management Americas Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.39 - $3.12 $91,079 - $204,438	-65,525 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $21,665 - $46,306	-5,952 Reduced 8.33%	65,525 $0
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $56,656 - $82,109	-9,427 Reduced 11.65%	71,477 $0
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $273,332 - $437,694	45,404 Added 127.9%	80,904 $0
Q1 2021 May 14, 2021	BUY	$9.17 - $14.8 $68,775 - $111,000	7,500 Added 26.79%	35,500 $0

Q4 2020 Mar 01, 2021	BUY	$8.92 - $13.29 $107,932 - $160,809	12,100 Added 76.1%	28,000 $0
Q3 2020 Nov 13, 2020	BUY	$9.94 - $16.59 $33,796 - $56,406	3,400 Added 27.2%	15,900 $0
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $19,312 - $30,944	1,600 Added 14.68%	12,500 $0
Q4 2019 Feb 14, 2020	BUY	$11.42 - $22.19 $124,478 - $241,871	10,900 New	10,900 $0

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.